![Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method - The Lancet Infectious Diseases Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/7a138e08-16c3-41fd-8107-1fff8bb422f0/gr1.jpg)
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method - The Lancet Infectious Diseases
![Polymers | Free Full-Text | Effect of Monomer Type on the Synthesis and Properties of Poly(Ethylene Furanoate) Polymers | Free Full-Text | Effect of Monomer Type on the Synthesis and Properties of Poly(Ethylene Furanoate)](https://pub.mdpi-res.com/polymers/polymers-15-02707/article_deploy/html/images/polymers-15-02707-g001-550.jpg?1686917238)
Polymers | Free Full-Text | Effect of Monomer Type on the Synthesis and Properties of Poly(Ethylene Furanoate)
![Solution‐Processed Two‐Dimensional MoS2 Nanosheets: Preparation, Hybridization, and Applications - Zhang - 2016 - Angewandte Chemie International Edition - Wiley Online Library Solution‐Processed Two‐Dimensional MoS2 Nanosheets: Preparation, Hybridization, and Applications - Zhang - 2016 - Angewandte Chemie International Edition - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ffab09f4-ef56-4bd6-9c04-5ff38748e32b/anie201509933-toc-0001-m.png)
Solution‐Processed Two‐Dimensional MoS2 Nanosheets: Preparation, Hybridization, and Applications - Zhang - 2016 - Angewandte Chemie International Edition - Wiley Online Library
![Dakar 2 Summit - Feed Africa: Food Sovereignty and Resilience | African Development Bank Group - Making a Difference Dakar 2 Summit - Feed Africa: Food Sovereignty and Resilience | African Development Bank Group - Making a Difference](https://www.afdb.org/sites/default/files/dakar2_banner2.jpg)
Dakar 2 Summit - Feed Africa: Food Sovereignty and Resilience | African Development Bank Group - Making a Difference
![Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study - The Lancet Microbe Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study - The Lancet Microbe](https://www.thelancet.com/cms/asset/fa17a484-040c-4399-bd32-b9b72e6e33ac/gr1.jpg)
Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study - The Lancet Microbe
Considerations for the use of face masks in the community in the context of the SARS-CoV-2 Omicron variant of concern
![Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial - The Lancet Oncology Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/d6622fb0-9069-436c-a3bd-a10885c23e2c/gr1.jpg)
Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicentre, open-label, single-arm, phase 2, basket trial - The Lancet Oncology
![RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection: Molecular Therapy - Nucleic Acids RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/a2a8e2bf-06b9-4036-9b70-7707a878322f/fx1_lrg.jpg)
RIG-I-induced innate antiviral immunity protects mice from lethal SARS-CoV-2 infection: Molecular Therapy - Nucleic Acids
![Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies - The Lancet Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies - The Lancet](https://www.thelancet.com/cms/attachment/8312cce9-0649-4da1-9ea6-fa80f2120e48/gr1.jpg)
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies - The Lancet
![Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium - The Lancet Digital Health Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium - The Lancet Digital Health](https://www.thelancet.com/cms/asset/a8e811f6-a3ae-410f-be8a-ec9ba07572bb/gr1.jpg)
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium - The Lancet Digital Health
![Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2: Molecular Therapy - Methods & Clinical Development Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/4d7dd4a7-b606-4fb0-91a7-81f36eebe6b0/fx1.jpg)